Rizzoli, René.
René Rizzoli researcher
Rizzoli, René, 19..-....
VIAF ID: 34697748 (Personal)
Permalink: http://viaf.org/viaf/34697748
Preferred Forms
- 100 0 _ ‡a René Rizzoli ‡c researcher
- 200 _ | ‡a Rizzoli ‡b René
- 100 1 _ ‡a Rizzoli, René
-
-
- 100 1 _ ‡a Rizzoli, René, ‡d 19..-....
-
-
- 100 1 _ ‡a Rizzoli, René
-
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Accurate prediction of rat proximal femur bone strength by in vivo DXA mesasurement of bone mass and femoral neck geometry | |
Alterations of calcium and phosphate metabolism in primary hyperparathyroidism during pregnancy | |
Aménorrhée et risque d'ostéoporose chez l'adolescente | |
Anorexie mentale et ses conséquences osseuses : une prise en charge difficile | |
Anziani in Svizzera : bilancio e prospettive : [rapporto della commissione federale "Invecchiare in Svizzera"] | |
Atlas of postmenopausal osteoporosis | |
Authors' reply | |
Behandlung der Osteoporose mit Bisphosphonaten | |
Le dosage de la parathormone, de la "parathyroid hormone-related protein" et des métabolites de la vitamine D dans l'évaluation de l'homéostase du calcium | |
Effect of a single infusion of alendronate in malignant hypercalcaemia : dose dependency and comparison with clodronate | |
Est-il nécessaire de traiter une femme qui ne présente pas de plainte lors de sa ménopause ? : patiente à risque d'ostéoporose | |
Etude ADIBOX : adiposité et métabolisme osseux : effets de la perte de poids induite par l'exercice chez les adolescents obèses | |
Évaluation de la microarchitecture trabéculaire et des propriétés mécaniques osseuses in vivo chez l'humain par scanner périphérique a haute résolution : application clinique à l'ostéoporose | |
Fracture du fémur proximal : une épidémie maîtrisée ? | |
Histo-anatomy of the proximal femur in rats : impact of ovariectomy on bone mass, structure, and stiffness | |
Low Lean Mass Predicts Incident Fractures Independently From FRAX: a Prospective Cohort Study of Recent Retirees. | |
Low protein intake is associated with impaired titanium implant osseointegration. | |
Maladies osseuses | |
Management of Hypoparathyroidism: Present and Future | |
[Milk products and bone growth] | |
New Targets and New Treatments: Recent Advances in the Treatment of Musculoskeletal Disease | |
Non-surgical treatment of primary hyperparathyroidism | |
Normal masticatory function partially protects the rat mandibular bone from estrogen-deficiency induced osteoporosis. | |
Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect | |
Les os des personnes infectées par le VIH sont-ils si fragiles? | |
Ostéoporose : acquisitions thérapeutiques 2004 | |
Ostéoporose cortisonique : prévention et traitement = Steroidinduzierte Osteoporose : Vorbeugung und Behandlung | |
Ostéoporose et traitement antiandrogénique du cancer de la prostate | |
Osteoporose in der Schweiz im Jahr 2008 : eine Aufforderung zur Tat | |
Osteoporose : von der osteodensitometrischen Diagnose zur Evaluation des absoluten Frakturrisikos | |
Parathyroid hormone-related protein : a polyhormone involved in growth, development and gestation | |
Patients’ preferences for osteoarthritis treatment: the value of stated-preference studies | |
Le peptide apparenté à la parathormone (PTHrP), un analogue de l'hormone parathyroïdienne impliqué dans la régulation de la croissance, du développement et de la gestation | |
Peripheral skeleton bone strength is positively correlated with total and dairy protein intakes in healthy postmenopausal women | |
The perspective of the International Osteoporosis Foundation on the official positions of the International Society for Clinical Densitometry | |
Phosphate homeostatis, 1,25-dihydroxyvitamin D₃, and hyperparathyroidism in early chronic renal failure | |
[Physical exercise and bone development in chronically ill children] | |
Le pic de masse osseuse : réalités et incertitudes | |
Potential role of IGF-1 in parathyroid hormone-related renal growth induced by hight protein diet in uninephrectomized rats | |
Preclinical evaluation of new therapeutic agents for osteoporosis | |
Prévention de la chute : un enjeu de taille dans la stratégie visant à prévenir les fractures chez le sujet âgé | |
Prophylactic injection of methylmetacrylate in vertebrae located between two previously cemented levels does not prevent a subsequent compression fracture in a patient with bone fragility | |
Proximal tibia volumetric bone mineral density is correlated to the magnitude of local acceleration in male long-distance runners | |
Publication outcomes of the abstracts presented at the 2011 European Congress on Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ECCEO-IOF11): A position paper of the European Society for Clinical and Economical Aspects of Osteoporosis, O | |
Quality of life in sarcopenia and frailty | |
Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels | |
Recovery after unilateral knee replacement due to severe osteoarthritis and progression in the contralateral knee: a randomised clinical trial comparing daily 2000 IU versus 800 IU vitamin D | |
Recovery of decreased bone mineral mass after lower-limb fractures in adolescents | |
Regulation of parathyroid hormone/parathyroid hormone-related protein receptor expression by osteoblast-deposited extracellular matrix in a human osteoblast-like cell line | |
Reply to D Xie and Z Sheng | |
Retentissements osseux de traitements thyroxiniques substitutifs ou freinateurs | |
The role of dual energy x-ray absorptiometry of lumbar spine and proximal femur in the diagnosis and follow-up of osteoporosis | |
The role of teriparatide in sequential and combination therapy of osteoporosis | |
Sarcopenia: burden and challenges for public health | |
Sarcopenia in daily practice: assessment and management. | |
Selective determinants of low bone mineral mass in adult women with anorexia nervosa. | |
Serum Levels of a Cathepsin-K Generated Periostin Fragment Predict Incident Low-Trauma Fractures in Postmenopausal Women Independently of BMD and FRAX. | |
A single bisphosphonate infusion is associated with improved functional capacity in elderly subjects with primary hyperparathyroidism | |
Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength. | |
Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC). | |
Tamoxifen et densité minérale osseuse | |
Thiazides et fracture du col fémoral | |
A thymoma as a cause of true ectopic hyperparathyroidism | |
[Tomodensitometry measurements of proximal tibia and acceleration in marathon athletes]. | |
Trabecular and cortical bone density and architecture in women after 60 days of bed rest using high-resolution pQCT: WISE 2005. | |
Tracking of environmental determinants of bone structure and strength development in healthy boys: an eight-year follow up study on the positive interaction between physical activity and protein intake from prepuberty to mid-late adolescence | |
Traitement de l'ostéoporose : nouveautés en médecine 2006 | |
Traitement de l'ostéoporose par l'hormone parathyroïdienne : pourquoi ? pour qui ? | |
Traitement et prévention de l'ostéoporose par les bisphosphonates | |
Transforming growth factor-β modulates the parathyroid hormone-related protein-induced responses in renal epithelial cells | |
Transgenic mice expressing high levels of soluble tumor necrosis factor receptor-1 fusion protein are protected from bone loss caused by estrogen deficiency | |
Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density | |
Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteop | |
Vitamin D supplementation: upper limit for safety revisited? | |
Within- and Across-Sex Inheritance of Bone Microarchitecture. | |
Zoledronic Acid for the treatment and prevention of primary and secondary osteoporosis |